Richard Burkhart, M.D., is an Associate Professor of Surgery at The Johns Hopkins Hospital with a focus on complex minimally-invasive surgery and research for cancers of the pancreas, liver and bile ducts. Dr. Burkhart received his medical degree from Boston University and completed his surgical residency and research fellowships at the Thomas Jefferson University Hospital in Philadelphia and the Cold Spring Harbor Laboratories. He is a member of several professional organizations, including the American Association of Cancer Research, the American College of Surgeons, the Society of Surgery for the Alimentary Tract, the Pancreas Club, and the Society of Surgical Oncology. Outside the operating room, Dr. Burkhart heads a multidisciplinary laboratory team dedicated to bringing next-generation precision medicine approaches into the routine clinical care of patients that we serve. He has a particular research interest in using personalized models of pancreas cancer, made from tumor during and immediately after surgical resection, to select the best chemotherapy for each patient to support long-term survival and improve rates of disease cure. The laboratory team, funded in part by the National Institutes of Health, the National Cancer Institute, the Lustgarten Foundation and Stand Up to Cancer, is also thankful to the many patients who have supported the work through philanthropic gift. Dr. Burkhart is highly rated in 15 conditions, according to our data. His top areas of expertise are Pancreatic Cancer, Pancreatic Ductal Adenocarcinoma, Familial Pancreatic Cancer, Pancreatectomy, and Pancreaticoduodenectomy.

Kelly Lafaro, MD, MPH, is a general surgeon with a specialty in gastrointestinal surgical oncology and hepatobiliary surgery. She is part of the Johns Hopkins Kimmel Cancer Center. Dr. Lafaro earned her medical degree from Tulane University School of Medicine and completed her residency at New York-Presbyterian/Columbia University Irving Medical Center. Her fellowship in complex general surgical oncology was completed at City of Hope National Medical Center. Dr. Lafaro’s expertise includes pancreatic adenocarcinoma, neuroendocrine tumors, minimally invasive pancreatic and liver surgeries, and colorectal liver metastases. In addition to her clinical experience, Dr. Lafaro is published in the field of liver and pancreatic cancer. She is interested in the improvement of surgical and post-surgical outcomes. Dr. Lafaro is highly rated in 13 conditions, according to our data. Her top areas of expertise are Pancreatic Cancer, Pancreatic Ductal Adenocarcinoma, Neuroendocrine Tumor, Pancreatectomy, and Pancreaticoduodenectomy.

Dr. Susan Bahl, MD, FACS, is a distinguished Breast Surgeon who recently joined Johns Hopkins, practicing at both Howard County Medical Center and Johns Hopkins Bayview Medical Center. A strong advocate for women's health, Dr. Bahl brings over a decade of experience in providing state-of-the-art, evidence-based breast care within multidisciplinary settings. She has a passion for delivering personalized treatment plans to patients, specializing in both benign and malignant breast diseases. Before joining Johns Hopkins, Dr. Bahl served as the Medical Director of the Frederick Health Breast Center, where she founded a NAPBC-accredited multidisciplinary breast cancer clinic. In this role, she helped streamline the treatment process for newly diagnosed breast cancer patients by coordinating care between breast surgeons, medical oncologists, and radiation oncologists. Dr. Bahl also co-directed a Breast Screening and Prevention Program designed for high-risk women, integrating genetic testing, risk-reduction surgeries, and chemo-prevention strategies. Her commitment to patient-centered care and leadership in breast health make her a valuable addition to the Johns Hopkins community. Dr. Bahl is highly rated in 11 conditions, according to our data. Her top areas of expertise are Breast Cancer, Paget Disease of the Breast, Angiosarcoma, Inflammatory Breast Cancer, and Lymphadenectomy.

Dr. Julie Lange is an assistant professor of surgery, dermatology and oncology at the Johns Hopkins University School of Medicine. Dr. Lange was one of the original members of the Johns Hopkins melanoma group when it was first formed in 1995 and now serves as a clinical co-director of the Melanoma Program. Dr. Lange introduced the sentinel node technique to Johns Hopkins for both melanoma and breast cancer in the 1990s and has extensive experience with this technique. Dr. Lange is a graduate of the Vanderbilt University School of Medicine and completed her general surgery training at Yale-New Haven Hospital. She completed a fellowship in surgical oncology and immunotherapy at the Surgery Branch of the National Cancer Institute as well. Dr. Lange joined the faculty of the Department of Surgery at Johns Hopkins in 1994 and subsequently earned a Sc.M. in clinical investigation at the Johns Hopkins Bloomberg School of Public Health. She has particular interest in melanoma at extremes of age, and in the factors associated with variance in melanoma care. Dr. Lange has published the largest study of melanoma in children, adolescents and young adults. She recognizes that melanoma in the older patient is a growing epidemic and has investigated the socioeconomic, demographic and healthcare factors that influence the treatment of melanoma in older persons. Dr. Lange is a member of the melanoma panel of the National Comprehensive Cancer Network, a group that annually evaluates and revises national treatment guidelines for melanoma. In 2015, she was inducted for her work into the Miller-Coulson Academy of Clinical Excellence, which recognizes outstanding clinicians at Johns Hopkins based on a number of factors, including communication and interpersonal skills, professionalism and humanism, a scholarly approach to clinical practice, and a passion for patient care. Dr. Lange is highly rated in 10 conditions, according to our data. Her top areas of expertise are Melanoma, Breast Cancer, Paget Disease of the Breast, Angiosarcoma, and Lymphadenectomy.

Christopher Shubert, M.D., M.H.A., is a general surgeon with specialty training and interests in hepato-pancreato-biliary (HPB) surgery. He is a member of the Division of Hepato-Pancreato-Biliary & Gastrointestinal Surgical Oncology at The Johns Hopkins Hospital. Dr. Shubert earned his medical degree from the University of Alabama School of Medicine and completed his general surgery residency at the Mayo Clinic in Rochester, Minnesota. He completed fellowship training in HPB surgical oncology and abdominal organ transplantation at the University of Toronto. In addition to his clinical experience, Dr. Shubert earned a Master's of Science in Healthcare Administration from the University of Alabama at Birmingham. Dr. Shubert's clinical interests include HPB surgery, resection of traditionally unresectable liver lesions, tumors involving the vena cava, and pancreas resections with vascular reconstruction. His research focus includes hepatobiliary and pancreatic malignancies, their respective treatments, perioperative management, and outcomes. Dr. Shubert is highly rated in 6 conditions, according to our data. His top areas of expertise are Pancreatic Cancer, Cholangiocarcinoma (Bile Duct Cancer), Pancreatic Ductal Adenocarcinoma, Pancreaticoduodenectomy, and Pancreatectomy.

Dr. Topalian is a physician-scientist whose studies of anti-tumor immunity have been foundational in developing cancer immunotherapy. She has published over 160 original research articles and reviews in this area and is one of the most highly cited researchers in the biomedical field. She received her medical and scientific training at Tufts University School of Medicine, Thomas Jefferson University Hospital, Children’s Hospital of Philadelphia and the National Cancer Institute. She joined the Johns Hopkins Kimmel Cancer Center in 2006 as the inaugural director of its Melanoma Program. Dr. Topalian is credited with advancing the clinical development of anti-PD-1 immunotherapy, and her work is widely recognized. She was named one of Nature’s 10 in 2014, and received the Karnofsky Award from ASCO in 2015, the Taubman Prize in 2016, the NCI’s Rosalind E. Franklin Award in 2018, the American Academy of Dermatology’s Gruber Memorial Cancer Research Award in 2020, and the Award for Distinguished Research in the Biomedical Sciences from the Association of American Medical Colleges in 2021 for landmark discoveries in cancer immunotherapy. Dr. Topalian was elected to the National Academy of Medicine in 2017, and to the American Association for Cancer Research Academy in 2022. Her work has opened new avenues of scientific investigation and established immunotherapy as a pillar of oncology. Dr. Topalian is highly rated in 3 conditions, according to our data. Her top areas of expertise are Merkel Cell Carcinoma, Melanoma, Neuroendocrine Tumor, and Anal Cancer.

Armando Sardi is a Surgical Oncologist in Baltimore, Maryland. Dr. Sardi is highly rated in 26 conditions, according to our data. His top areas of expertise are Pseudomyxoma Peritonei, Colorectal Cancer, Familial Colorectal Cancer, Ureteroscopy, and Hernia Surgery. Dr. Sardi is currently accepting new patients.

David Euhus is a Surgical Oncologist and a General Surgeon in Baltimore, Maryland. Dr. Euhus is highly rated in 9 conditions, according to our data. His top areas of expertise are Breast Cancer, Paget Disease of the Breast, Angiosarcoma, Mastectomy, and Lymphadenectomy.

Joseph Bennett is a Surgical Oncologist in Baltimore, Maryland. Dr. Bennett is highly rated in 63 conditions, according to our data. His top areas of expertise are Pancreatic Adenoma, Pancreatic Cancer, Familial Pancreatic Cancer, Pancreatectomy, and Small Bowel Resection.

Norman G. Nicolson, M.D., M.H.S., is an Assistant Professor of Surgery at the Johns Hopkins University School of Medicine and a surgical oncologist within the Division of HPB & Gastrointestinal Surgical Oncology. Dr. Nicolson completed his complex general surgical oncology clinical fellowship training and an NIH-funded T32 research fellowship at Johns Hopkins prior to joining the surgical faculty. Prior to this, he completed his undergraduate work at Williams College and medical degree at Northwestern University, followed by internship and residency in general surgery at Yale New Haven Hospital with a Masters in Health Sciences and research fellowship at Yale University. Dr. Nicolson specializes in treating patients with gastric cancer, peritoneal surface malignancy, appendiceal neoplasms, retroperitoneal sarcoma, gastrointestinal neuroendocrine and stromal tumors, and complex or recurrent tumors of the GI tract. He is trained in both minimally invasive and traditional open approaches to treating these cancers, utilizing laparoscopic or robotic approaches when appropriate. He emphasizes the importance of multi-disciplinary care and patient-centered decision-making, working closely with colleagues in medical and radiation oncology, gastroenterology, and radiology to provide comprehensive personalized cancer care appropriate to each individual. Dr. Nicolson's translational research focuses on computational and bioinformatics approaches to high-dimensional sequencing data from human biospecimens to better understand tumor cell biomarker heterogeneity and the importance of the tumor-draining lymph node in tumor-immune cell interactions in gastrointestinal tumors. He is a member of several academic and clinical professional societies, including the American College of Surgeons, the Association for Academic Surgery, the American Society for Clinical Oncology, the American Association for Cancer Research, and the Society of Surgical Oncology. Dr. Nicolson is highly rated in 4 conditions, according to our data. His top areas of expertise are Adrenocortical Carcinoma, Adrenal Cancer, Follicular Thyroid Cancer, Pancreaticoduodenectomy, and Thyroidectomy.

Marco Dal Molin, M.D., is a surgical oncologist that specializes in hepatobiliary, pancreatic and gastrointestinal surgical oncology at the Johns Hopkins Hospital. Dr. Dal Molin earned his medical degree at the University of Verona School of Medicine in Italy, followed by a general surgery residency at the University of Verona/Pancreas Institute. He completed a second general surgery residency at the University of Maryland in Baltimore, and a fellowship in Complex General Surgical Oncology at Johns Hopkins. Dr. Dal Molin received extensive postdoctoral research training at Johns Hopkins, including an NIH-funded T32 research fellowship prior to joining the surgical faculty. He specializes in the management of patients with pancreatic cancer, pancreatic cysts, as well as cancers of the liver, biliary tree and gastrointestinal tract. He is trained in traditional open and minimally invasive techniques to treating these cancers, using both laparoscopic and robotic approaches. Dr. Dal Molin’s research focuses on the development of liquid biopsies to improve the earlier detection and management of pancreatic cancer and pancreatic cysts. Another area of focus is the development of novel immunotherapies to treat pancreatic and hepatobiliary cancers. Dr. Molin is highly rated in 2 conditions, according to our data. His top areas of expertise are Pancreatic Cancer, Pancreatic Ductal Adenocarcinoma, Pancreaticoduodenectomy, and Hepato-Pancreato-Biliary Surgery.

Fabian Johnston is a Surgical Oncologist in Baltimore, Maryland. Dr. Johnston is highly rated in 28 conditions, according to our data. His top areas of expertise are Adult Soft Tissue Sarcoma, Stomach Cancer, Gastrointestinal Stromal Tumor, Splenectomy, and Pancreatectomy.

Arun Mavanur is a Surgical Oncologist in Baltimore, Maryland. Dr. Mavanur is highly rated in 13 conditions, according to our data. His top areas of expertise are Colorectal Cancer, Familial Colorectal Cancer, Pancreatic Cancer, Pancreatectomy, and Thyroidectomy.

Atsuko Okabe is a Surgical Oncologist in Rosedale, Maryland. Dr. Okabe is highly rated in 11 conditions, according to our data. Her top areas of expertise are Breast Cancer, Paget Disease of the Breast, Breast Lump, Intraductal Papilloma, and Lymphadenectomy.

Vadim Gushchin is a Surgical Oncologist in Lutherville, Maryland. Dr. Gushchin is highly rated in 10 conditions, according to our data. His top areas of expertise are Pseudomyxoma Peritonei, Colorectal Cancer, Familial Colorectal Cancer, Ureteral Reconstruction, and Small Bowel Resection. Dr. Gushchin is currently accepting new patients.

Debashish Bose is a Surgical Oncologist in Baltimore, Maryland. Dr. Bose is highly rated in 7 conditions, according to our data. His top areas of expertise are Pancreatic Pseudocyst, Pancreatic Cancer, Familial Pancreatic Cancer, Pancreatectomy, and Small Bowel Resection.

Kurtis Campbell is a Surgical Oncologist in Baltimore, Maryland. Dr. Campbell is highly rated in 7 conditions, according to our data. His top areas of expertise are Pancreatic Cancer, Familial Pancreatic Cancer, Familial Colorectal Cancer, Pancreatectomy, and Small Bowel Resection.

Suliat Nurudeen is a Surgical Oncologist and a General Surgeon in Baltimore, Maryland. Dr. Nurudeen is highly rated in 5 conditions, according to our data. Her top areas of expertise are Breast Cancer, Fibroadenoma, Giant Mammary Hamartoma, Mastectomy, and Lymphadenectomy. Dr. Nurudeen is currently accepting new patients.

Rebecca Dodson is a Surgical Oncologist in Baltimore, Maryland. Dr. Dodson has been practicing medicine for over 17 years is highly rated in 2 conditions, according to our data. Her top areas of expertise are Melanoma, Subareolar Abscess, Gastrointestinal Stromal Tumor, Pancreaticoduodenectomy, and Hepatectomy.

Mukund Didolkar is a Surgical Oncologist in Baltimore, Maryland. Dr. Didolkar is highly rated in 1 condition, according to our data. His top areas of expertise are Melanoma, Pancreatic Cancer, Familial Pancreatic Cancer, Pancreatectomy, and Small Bowel Resection.

Yinin Hu is a Surgical Oncologist in Baltimore, Maryland. Dr. Hu is highly rated in 12 conditions, according to our data. His top areas of expertise are Osteitis Fibrosa, Neonatal Severe Hyperparathyroidism, Parathyroid Hyperplasia, Thyroidectomy, and Gastrectomy.

John Saunders is a Surgical Oncologist in Towson, Maryland. His top areas of expertise are Renal Oncocytoma, Laryngeal Cancer, Throat Cancer, and Acinic Cell Carcinoma of Salivary Glands.

Humair Quadri is a Surgical Oncologist in Baltimore, Maryland. His top areas of expertise are Stomach Cancer, Pancreatic Cancer, Cholangiocarcinoma (Bile Duct Cancer), Small Bowel Resection, and Pancreatectomy.

Joshua Jolissaint is a Surgical Oncologist and a General Surgeon in Baltimore, Maryland. Dr. Jolissaint has been practicing medicine for over 10 years is highly rated in 2 conditions, according to our data. His top areas of expertise are Cholangiocarcinoma (Bile Duct Cancer), Chronic Pancreatitis, Hereditary Pancreatitis, Pancreatectomy, and Pancreaticoduodenectomy.

Eman Sbaity is a Surgical Oncologist in Baltimore, Maryland. Dr. Sbaity is highly rated in 1 condition, according to our data. Her top areas of expertise are Breast Cancer, Desmoid Tumor, Gastrointestinal Stromal Tumor, Adult Soft Tissue Sarcoma, and Pancreaticoduodenectomy.